Home Cart Sign in  
Chemical Structure| 519187-97-4 Chemical Structure| 519187-97-4

Structure of Edonerpic maleate
CAS No.: 519187-97-4

Chemical Structure| 519187-97-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Edonerpic maleate can inhibit amyloid-β peptides (Aβ) and used as a neurotrophic agent.

Synonyms: T-817 maleate; T-817MA; T-187MA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Edonerpic maleate

CAS No. :519187-97-4
Formula : C20H25NO6S
M.W : 407.48
SMILES Code : OC1CN(CCCOCCC2=CC=C3C(C=CS3)=C2)C1.O=C(O)/C=C\C(O)=O
Synonyms :
T-817 maleate; T-817MA; T-187MA
MDL No. :N/A
InChI Key :RLUCYBFCLXANSO-BTJKTKAUSA-N
Pubchem ID :11338749

Safety of Edonerpic maleate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Cortical neurons 1 and 10 μM within 2 h Attenuated traumatic neuronal injury and oxidative stress Cell Death Discov. 2022 Mar 4;8(1):95
DRG sensory neurons 20 µM overnight To evaluate the effect of Edonerpic maleate on sodium currents, results showed increased sodium current density. Channels (Austin). 2019 Dec;13(1):498-504
DRG sensory neurons 20 µM overnight To evaluate the effect of Edonerpic maleate on calcium currents, results showed inhibition of calcium current density. Channels (Austin). 2019 Dec;13(1):498-504
Dorsal root ganglia neurons 20 µM overnight To evaluate the effect of Edonerpic maleate on CRMP2 expression and phosphorylation, results showed no significant effect on CRMP2 expression and phosphorylation levels. Channels (Austin). 2019 Dec;13(1):498-504

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Post-surgical pain model Intraperitoneal injection 20 mg/kg Single dose, observed for 5 hours To evaluate the effect of Edonerpic maleate on post-surgical pain, results showed no reversal of post-surgical allodynia. Channels (Austin). 2019 Dec;13(1):498-504
SD rats Controlled cortical impact model Oral 30 mg/kg Once daily for 3 weeks Alleviated brain edema, neuronal loss, and microglial activation, improved long-term neurological function Cell Death Discov. 2022 Mar 4;8(1):95
Japanese macaques (Macaca fuscata) Unilateral C6-C7 spinal cord injury model Intramuscular injection 3 mg/kg/day Once daily for 2 months To evaluate the effect of Edonerpic maleate on motor function recovery after spinal cord injury. Results showed that the Edonerpic MA-treated group had significantly improved grasping movements compared to the control group, accompanied by cortical somatotopic reorganization. Brain Commun. 2025 Mar 13;7(2):fcaf036
Long-Evans rats Cryogenic brain injury model Oral 84 mg/kg body weight Administered 30 min before rehabilitative training, lasting for 14 days Edonerpic maleate enhances motor function recovery from brain damage by balancing excitatory and inhibitory synaptic inputs, which helps prevent epileptic seizures during recovery. Front Neural Circuits. 2024 Dec 6;18:1492043

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02693197 Healthy|Hepatic Impairment PHASE1 COMPLETED 2025-08-16 University of Miami, Miami, Fl... More >>orida, United States|Orlando Clinical Research Center, Orlando, Florida, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.45mL

0.49mL

0.25mL

12.27mL

2.45mL

1.23mL

24.54mL

4.91mL

2.45mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
 

Historical Records

Categories